Biologics for the prevention of reproductive and respiratory syndrome in pigs
The global market for Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live players cover Yongshun Creatures, Pfizer, Boehringer Ingelheim, Bayer and Elanco, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market, with both quantitative and qualitative data, to help readers understand how the Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Box.
Market Segmentation:
The study segments the Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market and forecasts the market size by Kinds (TJM-F92 Strain, GDr180 Strain and JXA1-R Strain), by Downstream (Farms and Individual.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by kinds
TJM-F92 Strain
GDr180 Strain
JXA1-R Strain
Other
Segmentation by downstream
Farms
Individual
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Yongshun Creatures
Pfizer
Boehringer Ingelheim
Bayer
Elanco
MSD
Cahic
Ringpu
Baoling
Jizhong
Dahuanong
Hayao
Pulike Biology
Tecon
Sinovet
Chapter Introduction
Chapter 1: Scope of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live, Research Methodology, etc.
Chapter 2: Executive Summary, global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market size (sales and revenue) and CAGR, Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market size by region, by kinds, by downstream, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by kinds, and kinds.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine, Live market size forecast by region, by country, by kinds, and downstream.
Chapter 13: Comprehensive company profiles of the leading players, including Yongshun Creatures, Pfizer, Boehringer Ingelheim, Bayer, Elanco, MSD, Cahic, Ringpu and Baoling, etc.
Chapter 14: Research Findings and Conclusion